There are several subtypes of CM. All types are positive for Darier’s sign (redness
and swelling due to local histamine release when touched.) They are diagnosed by biopsy, which show an
increased concentration of mast cells.
From this positive biopsy, they are differentiated based on the pattern
of skin lesions. The types of CM
include:
Urticaria pigmentosa (UP) is also called maculopapullar cutaneous
mastocytosis (MPCM.) This presentation
is by far the most common. UP is
characterized by tan or red/brown lesions that usually start on the trunk and may
eventually spread to other areas. UP
lesions are generally very itchy. It is
estimated that UP accounts for 65-90% of CM cases in children and 47-75%
overall. Systemic symptoms are sometimes
seen in people with UP, and some patients develop SM.
Solitary mastocytomas comprise approximately 17-51% of CM
cases and 10-35% of cases in children.
They are more common in children and are typically a single nodule on
one of the limbs. Multiple mastocytomas
are unusual. They often improve over
time.
Diffuse cutaneous mastocytosis (DCM) is rare, accounting for
1-5% of CM in children. DCM is the most
severe presentation of CM. It typically
presents in early infancy and is almost always diagnosed before 3 years of age. It involves lesions over a significant
portion of the body, some of which may blister and bleed. Thickening of the skin with age is
common. These patients often have
systemic symptoms, including flushing, itching, low blood pressure,
anaphylaxis, diarrhea and GI bleeding.
Telangiectasia macularis eruptive perstans is a rare form of
CM found almost exclusively in adults. Telangiectasia
are small blood vessels near the surface of the skin or mucous membranes. They are commonly called “spider veins.” These lesions are smaller than UP lesions and
generally don’t itch. Some patients with
TMEP develop SM.
Blistering can occur with any form of CM and is a function
of mast cell burden in the skin. Patients
with prominent, frequent blistering are more likely to experience systemic
symptoms and have a higher risk of anaphylaxis.
No comments:
Post a Comment